T. Matsui et al., CONTROL OF GASTRIC PH WITH RANITIDINE IN PATIENTS WITH CROHNS-DISEASERECEIVING TOTAL PARENTERAL-NUTRITION - COMPARISON OF 2 INTRAVENOUS REGIMENS, Journal of gastroenterology, 31(1), 1996, pp. 6-11
Eleven patients with Crohn's disease in remission who were receiving t
otal parenteral nutrition (TPN) underwent continuous intragastric 24-h
pH monitoring before and during ranitidine administration. The patien
ts were randomly allocated to receive 200 mg/ day (group 1) or 400 mg/
day (group 2) of ranitidine by continuous infusion. The mean basal 24-
h gastric pH was sustained at a low value. After raintidine administra
tion, the mean pH increased significantly both in group 1 (from 2.13 t
o 3.28) and in group 2 (from 1.91 to 3.36), with the mean holding-time
at pH-3 also increasing significantly in both groups. There were no d
ifferences in the mean pH or holding-time at pH-3 between the two grou
ps during ranitidine administration; however, the plasma ranitidine co
ncentration was significantly higher in group 2. These findings indica
te that the continuous infusion of a standard dose of ranitidine exert
ed a maximal inhibitory effect on the sustained hyperacidity induced b
y TPN, but that this infusion was unable to maintain the intragastric
pH level at above 3.5.